May 2 |
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
|
May 2 |
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
|
Apr 25 |
TAK or CTLT: Which Is the Better Value Stock Right Now?
|
Apr 11 |
Charles River (CRL) Forges Collaboration With Ship of Theseus
|
Apr 8 |
Novo Nordisk parent refiles US application on Catalent deal
|
Apr 8 |
UPDATE 1-Novo Nordisk parent refiles US application on Catalent deal
|
Apr 6 |
Ares, Blue Owl Lead $4.8 Billion Private Debt for Catalent Deal
|
Mar 28 |
13 Hot Stocks to Invest in According to Wall Street Analysts
|
Mar 9 |
The Top 3 Pharma Stocks to Buy in March 2024
|
Mar 8 |
HIGHLIGHTS-Novo Nordisk hopes to launch experimental obesity drug this decade
|